InvestorsHub Logo
Followers 22
Posts 3667
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Saturday, 03/09/2024 6:00:34 AM

Saturday, March 09, 2024 6:00:34 AM

Post# of 3017
Enanta Pharmaceuticals PATENTS new compounds for HBV and HDV - MARCH 9, 2024

Enanta Pharmaceuticals Inc. has disclosed new fused heterobicyclic derivatives reported to be useful for the treatment of hepatitis B virus (HBV) and hepatitis D virus (HDV) infections.

https://www.bioworld.com/topics/520-bioworld-science
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News